Stock CPH CIPHER PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Market Closed - Toronto S.E.
Other stock markets
 03:59:59 2024-04-15 pm EDT 		5-day change 1st Jan Change
9.32 CAD +0.16% Intraday chart for Cipher Pharmaceuticals Inc. +11.08% +68.23%
Mar. 15 Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
Mar. 14 Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
NE
Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.
CI
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges
MT
Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively
MT
Cipher Pharmaceuticals Brief: Q4 Total revenue was US$4.9 million, consistent with Q4 2022
MT
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
AQ
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
AQ
Cipher Pharmaceuticals Upgraded to Buy at Stifel GMP; Price Target Raised to C$8.00
MT
Cipher Pharmaceuticals Brief: Announcing that its common shares are now trading on the OTCQX Best Market
MT
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
AQ
Cipher Pharmaceuticals Announces Change of Auditor
AQ
Cipher Pharmaceuticals Announces Change of Auditor
AQ
Cipher Pharmaceuticals Announced Normal Course Issuer Bid
MT
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
AQ
Cipher Pharmaceuticals Brief: Announcing Normal Course Issuer Bid
MT
Cipher Pharmaceuticals Inc. announces an Equity Buyback for 1,337,195 shares, representing 5.57% of its issued share capital.
CI
Cipher Pharmaceuticals Inc. authorizes a Buyback Plan.
CI
Cipher Pharmaceuticals Seeks Acquisitions
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CPH Stock
  4. News Cipher Pharmaceuticals Inc.